1. Home
  2. CSBR vs PELI Comparison

CSBR vs PELI Comparison

Compare CSBR & PELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • PELI
  • Stock Information
  • Founded
  • CSBR 1985
  • PELI 2024
  • Country
  • CSBR United States
  • PELI United States
  • Employees
  • CSBR N/A
  • PELI N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • PELI
  • Sector
  • CSBR Health Care
  • PELI
  • Exchange
  • CSBR Nasdaq
  • PELI NYSE
  • Market Cap
  • CSBR 113.0M
  • PELI 119.7M
  • IPO Year
  • CSBR 1986
  • PELI 2025
  • Fundamental
  • Price
  • CSBR $8.24
  • PELI $9.96
  • Analyst Decision
  • CSBR Strong Buy
  • PELI
  • Analyst Count
  • CSBR 1
  • PELI 0
  • Target Price
  • CSBR $12.00
  • PELI N/A
  • AVG Volume (30 Days)
  • CSBR 38.4K
  • PELI 314.3K
  • Earning Date
  • CSBR 07-17-2025
  • PELI 01-01-0001
  • Dividend Yield
  • CSBR N/A
  • PELI N/A
  • EPS Growth
  • CSBR N/A
  • PELI N/A
  • EPS
  • CSBR 0.46
  • PELI N/A
  • Revenue
  • CSBR $58,591,000.00
  • PELI N/A
  • Revenue This Year
  • CSBR $15.11
  • PELI N/A
  • Revenue Next Year
  • CSBR $7.80
  • PELI N/A
  • P/E Ratio
  • CSBR $17.82
  • PELI N/A
  • Revenue Growth
  • CSBR 19.03
  • PELI N/A
  • 52 Week Low
  • CSBR $3.60
  • PELI $10.01
  • 52 Week High
  • CSBR $11.99
  • PELI $10.43
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 69.99
  • PELI N/A
  • Support Level
  • CSBR $6.27
  • PELI N/A
  • Resistance Level
  • CSBR $8.58
  • PELI N/A
  • Average True Range (ATR)
  • CSBR 0.64
  • PELI 0.00
  • MACD
  • CSBR 0.28
  • PELI 0.00
  • Stochastic Oscillator
  • CSBR 96.63
  • PELI 0.00

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About PELI PELICAN ACQUISITION CORPORATION

Pelican Acquisition Corp is a blank check company.

Share on Social Networks: